{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:36:07Z","timestamp":1789504567608,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To perform a systematic review on published cases of subacute thyroiditis (SAT) secondary to SARS-CoV-2 vaccination, to highlight main features and increase the awareness of this condition.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Original reports of SAT developed after SARS-CoV-2 vaccination (mRNA, viral vector, or inactivated virus vaccines) were retrieved from a search of electronic databases. Individual patient data on demographics, medical history, type of vaccine, workup and therapies were collected. Wilcoxon rank-sum, Kruskal\u2013Wallis and chi-squared tests were employed for comparisons.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>30 articles including 48 reports were retrieved, 3 additional cases evaluated by the Authors were described and included for analysis. Of the 51 patients, 38 (74.5%) were women, median age was 39.5\u00a0years (IQR 34\u201347). Patients developed SAT after a median of 10\u00a0days (IQR 4\u201314) after the vaccine shot. Baseline thyroid exams revealed thyrotoxicosis in 88.2% of patients, decreasing at 31.6% at follow-up. Corticosteroids were used in 56.4% of treated patients. Patients undergoing non-mRNA vaccines were most frequently Asian (<jats:italic>p<\/jats:italic>\u2009=\u20090.019) and reported more frequently weight loss (<jats:italic>p<\/jats:italic>\u2009=\u20090.021). All patients with a previous diagnosis of thyroid disease belonged to the mRNA vaccine group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>SARS-CoV-2 vaccine-associated SAT is a novel entity that should be acknowledged by physicians. Previous history of thyroid disease may predispose to develop SAT after mRNA vaccines, but further studies and larger cohorts are needed to verify this suggestion. SARS-CoV-2 vaccine-associated SAT is usually of mild\/moderate severity and could be easily treated in most cases, thus it should not raise any concern regarding the need to be vaccinated.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40618-022-01747-0","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T19:02:16Z","timestamp":1643482936000},"page":"1189-1200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2982-3153","authenticated-orcid":false,"given":"S.","family":"Ippolito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Patera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Lanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. F. M.","family":"Fazzino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Piantanida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Tanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,29]]},"reference":[{"key":"1747_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/BF03348138","volume":"10","author":"E Martino","year":"1987","unstructured":"Martino E, Buratti L, Bartalena L, Mariotti S, Cupini C et al (1987) High prevalence of subacute thyroiditis during summer season in Italy. J Endocrinol Invest 10:321\u2013323. https:\/\/doi.org\/10.1007\/BF03348138","journal-title":"J Endocrinol Invest"},{"key":"1747_CR2","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1210\/clinem\/dgaa537","volume":"105","author":"A Brancatella","year":"2020","unstructured":"Brancatella A, Ricci D, Cappellani D, Viola N, Sgro D et al (2020) Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? Insights from a case series. J Clin Endocrinol Metab 105:2367\u20132370. https:\/\/doi.org\/10.1210\/clinem\/dgaa537","journal-title":"J Clin Endocrinol Metab"},{"key":"1747_CR3","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s40618-020-01312-7","volume":"43","author":"S Ippolito","year":"2020","unstructured":"Ippolito S, Dentali F, Tanda ML (2020) SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. J Endocrinol Invest 43:1171\u20131172. https:\/\/doi.org\/10.1007\/s40618-020-01312-7","journal-title":"J Endocrinol Invest"},{"key":"1747_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-8587(20)30266-7","volume":"8","author":"I Muller","year":"2020","unstructured":"Muller I, Cannavaro D, Dazzi D, Covelli D, Mantovani G et al (2020) SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol 8:739\u2013741. https:\/\/doi.org\/10.1016\/S2213-8587(20)30266-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1747_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s42000-020-00230-w","volume":"20","author":"RM Ruggeri","year":"2021","unstructured":"Ruggeri RM, Campenni A, Siracusa M, Frazzetto G, Gullo D (2021) Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones (Athens) 20:219\u2013221. https:\/\/doi.org\/10.1007\/s42000-020-00230-w","journal-title":"Hormones (Athens)"},{"key":"1747_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.707726","volume":"12","author":"P Trimboli","year":"2021","unstructured":"Trimboli P, Cappelli C, Croce L, Scappaticcio L, Chiovato L, Rotondi M (2021) COVID-19-associated subacute thyroiditis: evidence-based data from a systematic review. Front Endocrinol (Lausanne) 12:707726. https:\/\/doi.org\/10.3389\/fendo.2021.707726","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1747_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1743-422x-6-5","volume":"6","author":"R Desailloud","year":"2009","unstructured":"Desailloud R, Hober D (2009) Viruses and thyroiditis: an update. Virol J 6:5. https:\/\/doi.org\/10.1186\/1743-422x-6-5","journal-title":"Virol J"},{"key":"1747_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01628-y","author":"AM Poma","year":"2021","unstructured":"Poma AM, Bonuccelli D, Giannini R, Macerola E, Vignali P et al (2021) COVID-19 autopsy cases: detection of virus in endocrine tissues. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-021-01628-y","journal-title":"J Endocrinol Invest"},{"key":"1747_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01722-1","author":"ML Tanda","year":"2022","unstructured":"Tanda ML, Ippolito S, Gallo D, Baj A, Novazzi F et al (2022) SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction? J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-021-01722-1","journal-title":"J Endocrinol Invest"},{"key":"1747_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1210\/jcem-45-2-270","volume":"45","author":"S Nyulassy","year":"1977","unstructured":"Nyulassy S, Hnilica P, Buc M, Guman M, Hirschova V, Stefanovic J (1977) Subacute (de Quervain\u2019s) thyroiditis: association with HLA-Bw35 antigen and abnormalities of the complement system, immunoglobulins and other serum proteins. J Clin Endocrinol Metab 45:270\u2013274. https:\/\/doi.org\/10.1210\/jcem-45-2-270","journal-title":"J Clin Endocrinol Metab"},{"key":"1747_CR11","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/BF03346633","volume":"33","author":"CM Girgis","year":"2010","unstructured":"Girgis CM, Russo RR, Benson K (2010) Subacute thyroiditis following the H1N1 vaccine. J Endocrinol Invest 33:506. https:\/\/doi.org\/10.1007\/BF03346633","journal-title":"J Endocrinol Invest"},{"key":"1747_CR12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1080\/21645515.2015.1117716","volume":"12","author":"FA Altay","year":"2016","unstructured":"Altay FA, Guz G, Altay M (2016) Subacute thyroiditis following seasonal influenza vaccination. Hum Vaccin Immunother 12:1033\u20131034. https:\/\/doi.org\/10.1080\/21645515.2015.1117716","journal-title":"Hum Vaccin Immunother"},{"key":"1747_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/s1607-551x(09)70315-8","volume":"22","author":"JY Hsiao","year":"2006","unstructured":"Hsiao JY, Hsin SC, Hsieh MC, Hsia PJ, Shin SJ (2006) Subacute thyroiditis following influenza vaccine (Vaxigrip) in a young female. Kaohsiung J Med Sci 22:297\u2013300. https:\/\/doi.org\/10.1016\/s1607-551x(09)70315-8","journal-title":"Kaohsiung J Med Sci"},{"key":"1747_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12026-014-8567-3","volume":"61","author":"P Pellegrino","year":"2015","unstructured":"Pellegrino P, Perrone V, Pozzi M, Carnovale C, Perrotta C et al (2015) The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems. Immunol Res 61:90\u201396. https:\/\/doi.org\/10.1007\/s12026-014-8567-3","journal-title":"Immunol Res"},{"key":"1747_CR15","doi-asserted-by":"publisher","unstructured":"Xie Q, Mu XY, Li SQ (2021) Subacute thyroiditis following HPV vaccination: a case report. Sichuan Da Xue Xue Bao Yi Xue Ban 52:1047\u20131048. https:\/\/doi.org\/10.12182\/20211160506.","DOI":"10.12182\/20211160506"},{"key":"1747_CR16","first-page":"135","volume":"45","author":"J Toft","year":"1998","unstructured":"Toft J, Larsen S, Toft H (1998) Subacute thyroiditis after hepatitis B vaccination. Endocr J 45:135","journal-title":"Endocr J"},{"key":"1747_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01681-7","author":"L Das","year":"2021","unstructured":"Das L, Bhadada SK, Sood A (2021) Post-COVID-vaccine autoimmune\/inflammatory syndrome in response to adjuvants (ASIA syndrome) manifesting as subacute thyroiditis. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-021-01681-7","journal-title":"J Endocrinol Invest"},{"key":"1747_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","volume":"36","author":"Y Shoenfeld","year":"2011","unstructured":"Shoenfeld Y, Agmon-Levin N (2011) \u2019ASIA\u2019\u2013autoimmune\/inflammatory syndrome induced by adjuvants. J Autoimmun 36:4\u20138. https:\/\/doi.org\/10.1016\/j.jaut.2010.07.003","journal-title":"J Autoimmun"},{"key":"1747_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2020.101412","volume":"34","author":"NL Bragazzi","year":"2020","unstructured":"Bragazzi NL, Hejly A, Watad A, Adawi M, Amital H, Shoenfeld Y (2020) ASIA syndrome and endocrine autoimmune disorders. Best Pract Res Clin Endocrinol Metab 34:101412. https:\/\/doi.org\/10.1016\/j.beem.2020.101412","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1747_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108480","volume":"217","author":"A Vojdani","year":"2020","unstructured":"Vojdani A, Kharrazian D (2020) Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol 217:108480. https:\/\/doi.org\/10.1016\/j.clim.2020.108480","journal-title":"Clin Immunol"},{"key":"1747_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102792","volume":"20","author":"A Dotan","year":"2021","unstructured":"Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y (2021) The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev 20:102792. https:\/\/doi.org\/10.1016\/j.autrev.2021.102792","journal-title":"Autoimmun Rev"},{"key":"1747_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","volume":"134","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol 134:178\u2013189. https:\/\/doi.org\/10.1016\/j.jclinepi.2021.03.001","journal-title":"J Clin Epidemiol"},{"key":"1747_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.737142","volume":"8","author":"C Bornemann","year":"2021","unstructured":"Bornemann C, Woyk K, Bouter C (2021) Case report: two cases of subacute thyroiditis following SARS-CoV-2 vaccination. Front Med (Lausanne) 8:737142. https:\/\/doi.org\/10.3389\/fmed.2021.737142","journal-title":"Front Med (Lausanne)"},{"key":"1747_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01725-y","author":"M Capezzone","year":"2022","unstructured":"Capezzone M, Tosti-Balducci M, Morabito E, Caldarelli G, Sagnella A et al (2022) Silent thyroiditis following vaccination against COVID-19: report of two cases. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-021-01725-y","journal-title":"J Endocrinol Invest"},{"key":"1747_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-021-00332-z","author":"S Chatzi","year":"2021","unstructured":"Chatzi S, Karampela A, Spiliopoulou C, Boutzios G (2021) Subacute thyroiditis after SARS-CoV-2 vaccination: a report of two sisters and summary of the literature. Hormones (Athens). https:\/\/doi.org\/10.1007\/s42000-021-00332-z","journal-title":"Hormones (Athens)"},{"key":"1747_CR26","doi-asserted-by":"publisher","unstructured":"Faheem M, Motlaghzadeh Y, Jankovic I, Dosiou C (2021) Painless thyroiditis after mrna vaccination for severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102). Thyroid 31:A-1-A-114. http:\/\/doi.org\/https:\/\/doi.org\/10.1089\/thy.2021.29115.abstracts.","DOI":"10.1089\/thy.2021.29115.abstracts"},{"key":"1747_CR27","doi-asserted-by":"publisher","first-page":"A956","DOI":"10.1210\/jendso\/bvab048.1954","volume":"5","author":"S Franquemont","year":"2021","unstructured":"Franquemont S, Galvez J (2021) Subacute thyroiditis after mRNA vaccine for COVID-19. J Endocrine Soc 5:A956\u2013A957. https:\/\/doi.org\/10.1210\/jendso\/bvab048.1954","journal-title":"J Endocrine Soc"},{"key":"1747_CR28","doi-asserted-by":"publisher","first-page":"CC7","DOI":"10.1530\/endoabs.77.CC7","volume":"77","author":"R Goindoo","year":"2021","unstructured":"Goindoo R, Vankayalapati P, Mohammadi A (2021) COVID-19 AstraZeneca Vaccination Induced Subacute Thyroiditis. Endocr Abstr 77:CC7. https:\/\/doi.org\/10.1530\/endoabs.77.CC7","journal-title":"Endocr Abstr"},{"key":"1747_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2021.11.002","author":"J Gonzalez Lopez","year":"2021","unstructured":"Gonzalez Lopez J, Martin Nino I, Arana Molina C (2021) Subacute thyroiditis after SARS-CoV-2 vaccination: report of two clinical cases. Med Clin (Barc). https:\/\/doi.org\/10.1016\/j.medcli.2021.11.002","journal-title":"Med Clin (Barc)"},{"key":"1747_CR30","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1210\/clinem\/dgab373","volume":"106","author":"BG Iremli","year":"2021","unstructured":"Iremli BG, Sendur SN, Unluturk U (2021) Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: postvaccination ASIA syndrome. J Clin Endocrinol Metab 106:2600\u20132605. https:\/\/doi.org\/10.1210\/clinem\/dgab373","journal-title":"J Clin Endocrinol Metab"},{"key":"1747_CR31","doi-asserted-by":"publisher","unstructured":"Suarez J, Saco SB, Manzano A, Trotter M (2021) Covid\u201019 pfizer\u2010biontech vaccine\u2010induced painless thyroiditis: a case report. Thyroid 31:A-1-A-114. https:\/\/doi.org\/10.1089\/thy.2021.29115.abstracts.","DOI":"10.1089\/thy.2021.29115.abstracts"},{"key":"1747_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-246425","volume":"14","author":"MS Jeeyavudeen","year":"2021","unstructured":"Jeeyavudeen MS, Patrick AW, Gibb FW, Dover AR (2021) COVID-19 vaccine-associated subacute thyroiditis: an unusual suspect for de Quervain's thyroiditis. BMJ Case Rep 14:e246425. https:\/\/doi.org\/10.1136\/bcr-2021-246425","journal-title":"BMJ Case Rep"},{"key":"1747_CR33","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-21-0142","author":"F Khan","year":"2021","unstructured":"Khan F (2021) Brassill MJ (2021) Subacute thyroiditis post-Pfizer-BioNTech mRNA vaccination for COVID-19. Endocrinol Diabetes Metab Case Rep. https:\/\/doi.org\/10.1530\/EDM-21-0142","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"1747_CR34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejim.2021.10.008","volume":"94","author":"A Kyriacou","year":"2021","unstructured":"Kyriacou A, Ioakim S, Syed AA (2021) COVID-19 vaccination and a severe pain in the neck. Eur J Intern Med 94:95\u201396. https:\/\/doi.org\/10.1016\/j.ejim.2021.10.008","journal-title":"Eur J Intern Med"},{"key":"1747_CR35","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s12020-021-02898-5","volume":"74","author":"KA Lee","year":"2021","unstructured":"Lee KA, Kim YJ, Jin HY (2021) Thyrotoxicosis after COVID-19 vaccination: seven case reports and a literature review. Endocrine 74:470\u2013472. https:\/\/doi.org\/10.1007\/s12020-021-02898-5","journal-title":"Endocrine"},{"key":"1747_CR36","doi-asserted-by":"publisher","first-page":"LB30","DOI":"10.1530\/endoabs.77.LB30","volume":"77","author":"C McClements","year":"2021","unstructured":"McClements C, Challapalli C, McAulay V, Stewart F (2021) Pericarditis and sub-acute thyroiditis complicating Pfizer-BioNTech Covid-19 vaccination. Endocr Abstr 77:LB30. https:\/\/doi.org\/10.1530\/endoabs.77.LB30","journal-title":"Endocr Abstr"},{"key":"1747_CR37","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16045","volume":"13","author":"SO Oyibo","year":"2021","unstructured":"Oyibo SO (2021) Subacute thyroiditis after receiving the adenovirus-vectored vaccine for coronavirus disease (COVID-19). Cureus 13:e16045. https:\/\/doi.org\/10.7759\/cureus.16045","journal-title":"Cureus"},{"key":"1747_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.aace.2021.12.002","author":"M Pandya","year":"2021","unstructured":"Pandya M, Thota G, Wang X, Luo H (2021) Thyroiditis after coronavirus disease 2019 (COVID-19) mRNA vaccine: a case series. AACE Clin Case Rep. https:\/\/doi.org\/10.1016\/j.aace.2021.12.002","journal-title":"AACE Clin Case Rep"},{"key":"1747_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2021.103211","volume":"43","author":"KR Patel","year":"2022","unstructured":"Patel KR, Cunnane ME, Deschler DG (2022) SARS-CoV-2 vaccine-induced subacute thyroiditis. Am J Otolaryngol 43:103211. https:\/\/doi.org\/10.1016\/j.amjoto.2021.103211","journal-title":"Am J Otolaryngol"},{"key":"1747_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01739-0","author":"B Pla Peris","year":"2022","unstructured":"Pla Peris B, Merchante Alfaro AA, Maravall Royo FJ, Abellan Galiana P, Perez Naranjo S, Gonzalez Boillos M (2022) Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-022-01739-0","journal-title":"J Endocrinol Invest"},{"key":"1747_CR41","doi-asserted-by":"publisher","first-page":"8952048","DOI":"10.1155\/2021\/8952048","volume":"2021","author":"L Plaza-Enriquez","year":"2021","unstructured":"Plaza-Enriquez L, Khatiwada P, Sanchez-Valenzuela M, Sikha A (2021) A case report of subacute thyroiditis following mRNA COVID-19 vaccine. Case Rep Endocrinol 2021:8952048. https:\/\/doi.org\/10.1155\/2021\/8952048","journal-title":"Case Rep Endocrinol"},{"key":"1747_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01707-0","author":"A Pujol","year":"2021","unstructured":"Pujol A, Gomez LA, Gallegos C, Nicolau J, Sanchis P et al (2021) Thyroid as a target of adjuvant autoimmunity\/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves\u2019 disease to silent thyroiditis. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-021-01707-0","journal-title":"J Endocrinol Invest"},{"key":"1747_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14555","author":"GM Ratnayake","year":"2021","unstructured":"Ratnayake GM, Dworakowska D, Grossman AB (2021) Can COVID-19 immunisation cause subacute thyroiditis? Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/cen.14555","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1747_CR44","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab822","author":"LM Raven","year":"2021","unstructured":"Raven LM, McCormack AI, Greenfield JR (2021) Letter to the editor from raven: three cases of subacute thyroiditis following SARS-CoV-2 Vaccine. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgab822","journal-title":"J Clin Endocrinol Metab"},{"key":"1747_CR45","doi-asserted-by":"publisher","unstructured":"Sahin Tekin M, Saylisoy S, Yorulmaz G (2021) Subacute thyroiditis following COVID-19 vaccination in a 67-year-old male patient: a case report. Hum Vaccin Immunother:1\u20133. https:\/\/doi.org\/10.1080\/21645515.2021.1947102.","DOI":"10.1080\/21645515.2021.1947102"},{"key":"1747_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-244711","volume":"14","author":"ES Saygili","year":"2021","unstructured":"Saygili ES, Karakilic E (2021) Subacute thyroiditis after inactive SARS-CoV-2 vaccine. BMJ Case Rep 14:e244711. https:\/\/doi.org\/10.1136\/bcr-2021-244711","journal-title":"BMJ Case Rep"},{"key":"1747_CR47","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1089\/thy.2021.0184","volume":"31","author":"J Schimmel","year":"2021","unstructured":"Schimmel J, Alba EL, Chen A, Russell M, Srinath R (2021) Letter to the editor: thyroiditis and thyrotoxicosis after the SARS-CoV-2 mRNA vaccine. Thyroid 31:1440. https:\/\/doi.org\/10.1089\/thy.2021.0184","journal-title":"Thyroid"},{"key":"1747_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2021.100136","volume":"12","author":"A Siolos","year":"2021","unstructured":"Siolos A, Gartzonika K, Tigas S (2021) Thyroiditis following vaccination against COVID-19: report of two cases and review of the literature. Metabol Open 12:100136. https:\/\/doi.org\/10.1016\/j.metop.2021.100136","journal-title":"Metabol Open"},{"key":"1747_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.4812","volume":"9","author":"P Soltanpoor","year":"2021","unstructured":"Soltanpoor P, Norouzi G (2021) Subacute thyroiditis following COVID-19 vaccination. Clin Case Rep 9:e04812. https:\/\/doi.org\/10.1002\/ccr3.4812","journal-title":"Clin Case Rep"},{"key":"1747_CR50","doi-asserted-by":"publisher","unstructured":"Sozen M, Topaloglu O, Cetinarslan B, Selek A, Canturk Z, et al (2021) COVID-19 mRNA vaccine may trigger subacute thyroiditis. Hum Vaccin Immunother:1\u20136. https:\/\/doi.org\/10.1080\/21645515.2021.2013083.","DOI":"10.1080\/21645515.2021.2013083"},{"key":"1747_CR51","doi-asserted-by":"publisher","unstructured":"Thota G, Luo H (2021) COVID Vaccine induced subacute thyroiditis. Thyroid 31:A-1-A-114. 31. https:\/\/doi.org\/10.1089\/thy.2021.29115.abstracts","DOI":"10.1089\/thy.2021.29115.abstracts"},{"key":"1747_CR52","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1210\/jc.2002-021799","volume":"88","author":"V Fatourechi","year":"2003","unstructured":"Fatourechi V, Aniszewski JP, Fatourechi GZ, Atkinson EJ, Jacobsen SJ (2003) Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J Clin Endocrinol Metab 88:2100\u20132105. https:\/\/doi.org\/10.1210\/jc.2002-021799","journal-title":"J Clin Endocrinol Metab"},{"key":"1747_CR53","doi-asserted-by":"publisher","unstructured":"Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, et al (2016) 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26:1343-1421. https:\/\/doi.org\/10.1089\/thy.2016.0229","DOI":"10.1089\/thy.2016.0229"},{"key":"1747_CR54","doi-asserted-by":"publisher","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","volume":"15","author":"BM Chen","year":"2021","unstructured":"Chen BM, Cheng TL, Roffler SR (2021) Polyethylene glycol immunogenicity: theoretical, clinical, and practical aspects of anti-polyethylene glycol antibodies. ACS Nano 15:14022\u201314048. https:\/\/doi.org\/10.1021\/acsnano.1c05922","journal-title":"ACS Nano"},{"key":"1747_CR55","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/cea.13874","volume":"51","author":"P Sellaturay","year":"2021","unstructured":"Sellaturay P, Nasser S, Islam S, Gurugama P, Ewan PW (2021) Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer\/BioNTech mRNA COVID-19 vaccine. Clin Exp Allergy 51:861\u2013863. https:\/\/doi.org\/10.1111\/cea.13874","journal-title":"Clin Exp Allergy"},{"key":"1747_CR56","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41562-021-01122-8","volume":"5","author":"E Mathieu","year":"2021","unstructured":"Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J et al (2021) A global database of COVID-19 vaccinations. Nat Hum Behav 5:947\u2013953. https:\/\/doi.org\/10.1038\/s41562-021-01122-8","journal-title":"Nat Hum Behav"},{"key":"1747_CR57","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/794943","volume":"2014","author":"AA Alfadda","year":"2014","unstructured":"Alfadda AA, Sallam RM, Elawad GE, Aldhukair H, Alyahya MM (2014) Subacute thyroiditis: clinical presentation and long term outcome. Int J Endocrinol 2014:794943. https:\/\/doi.org\/10.1155\/2014\/794943","journal-title":"Int J Endocrinol"},{"key":"1747_CR58","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/BF03344178","volume":"29","author":"F Bogazzi","year":"2006","unstructured":"Bogazzi F, Dell\u2019Unto E, Tanda ML, Tomisti L, Cosci C et al (2006) Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis. J Endocrinol Invest 29:694\u2013699. https:\/\/doi.org\/10.1007\/BF03344178","journal-title":"J Endocrinol Invest"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01747-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-022-01747-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01747-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T10:40:13Z","timestamp":1652352013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-022-01747-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,29]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1747"],"URL":"https:\/\/doi.org\/10.1007\/s40618-022-01747-0","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,29]]},"assertion":[{"value":"4 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that no conflict of interests prejudicing the impartiality of the research reported exist. Silvia Ippolito,\u00a0Maria Laura Tanda, Daniela Gallo, Eliana Piantanida are members of the Editorial Board of the Journal of Endocrinological Investigation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All procedures\u00a0involving human participants performed were in accordance with the ethical standards of institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The ethical committee approval is not required for systematic reviews nor for case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent for publication was obtained from\u00a0 patients evaluated by Authors data were anonymized.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}